NIFTY 50▼25,057.35
-70.60 (-0.28%)
SENSEX▼81,820.12
-152.93 (-0.19%)
NIFTY BANK▲51,906.00
89.10 (0.17%)
TATA MOTORS▼917.30
-10.95 (-1.18%)
SUZLON ENERGY▼73.71
-0.30 (-0.41%)
TATA STEEL▼155.63
-2.69 (-1.70%)
INDIAN RAILWAY FINANCE CORP▼151.10
-0.25 (-0.17%)
TATA POWER▲463.50
1.20 (0.26%)
RAIL VIKAS NIGAM▲474.20
3.70 (0.79%)
RELIANCE INDUSTRIES▼2,688.05
-57.00 (-2.08%)
VODAFONE IDEA▲9.12
0.03 (0.33%)
RELIANCE POWER▲44.37
0.84 (1.93%)
ZOMATO▼279.55
-0.50 (-0.18%)
INDIAN RENEWABLE ENERGY▲222.68
1.18 (0.53%)
ADANI POWER▼633.90
-0.55 (-0.09%)
YES BANK▲21.20
0.15 (0.71%)
STATE BANK OF INDIA▼804.65
-0.50 (-0.06%)
NHPC▼90.01
-1.05 (-1.15%)
HDFC BANK▼1,684.10
-4.00 (-0.24%)
JIO FIN SERVICES LTD▼336.75
-3.30 (-0.97%)
OLA ELECTRIC MOBILITY LTD▲89.51
2.05 (2.34%)
BHARAT ELECTRONICS▲288.85
3.15 (1.10%)
INDIAN OIL CORP▲167.93
2.46 (1.49%)
GTL INFRA▼2.30
-0.02 (-0.86%)
ADANI PORT & SEZ▲1,420.30
10.00 (0.71%)
MRF▼1,31,027.25
-886.05 (-0.67%)
JAIPRAKASH POWER VENTURES▲21.39
0.07 (0.33%)
INDIAN RAILWAY TOURISM CORP▲895.30
10.30 (1.16%)
TRANSGENE BIOTEK LTD Share Price
TRABI
₹7.79+₹0.10 (1.30%) TodayLast updated on 15 Oct, 2024 | 15:29 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹8.05 | Close₹7.69 |
Circuit range₹8.07 - ₹7.31 | Day range₹7.60 - ₹8.05 | Year range₹3.84 - ₹12.46 |
Volume8,437 | Avg. traded₹7.71 | Revenue (12m)₹0 Crs |
TRANSGENE BIOTEK LTDTransgene Biotek Limited is an India-based biotechnology company. The Company is engaged in the research and development of vaccines, oncology and new drug delivery technologies. Its portfolio of products includes oncology, auto-immunity, drug delivery and biogenerics. The Company offers TrabiAAV, which is a platform for the delivery of micro ribonucleic acids (miRNAs), short hairpin RNA (ShRNAs), immunogens developing clinical significance in gene therapy and CRISPR/cas 9 technologies. Its monoclonal antibody therapy is the use of monoclonal antibodies to specifically bind to target cells. Its TrabiORAL is focused on delivering proteins and peptides orally for a variety of human diseases. Its TBL-1203, is used to strengthen cell-mediated immunity and complete elimination of the human immunodeficiency virus (HIV), without any need for retroviral drug therapy. Its Tacrolimus is a drug that suppresses the immune system and is mainly used to prevent rejection of transplanted organs.
TRANSGENE BIOTEK LTD Key indicators
52 week high₹12.46 | 52 week low₹3.84 | P/E ratio |
P/B ratio5.39 | ROE-- | ROCE-57.49% |
Dividend yield-- | Debt/Equity ratio-2.11 | EPS-0.79 |
Learn more
Featured in
Investment checklist: (2/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Fundamentals
Financial ratios
Operating profit margin-789.22% | Net profit margin0% |
ROE0% | ROA-17.24% |
ROCE-57.49% |
Learn more
TRANSGENE BIOTEK LTD Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Mon, Oct 14 2024 | ₹7.77 | ₹7.69 | -0.90% |
Fri, Oct 11 2024 | ₹8.07 | ₹7.76 | |
Thu, Oct 10 2024 | ₹8.18 | ₹7.69 | -1.41% |
Wed, Oct 9 2024 | ₹8.10 | ₹7.80 | |
Tue, Oct 8 2024 | ₹7.50 | ₹7.79 | |
Mon, Oct 7 2024 | ₹7.78 | ₹7.58 | -2.57% |
Fri, Oct 4 2024 | ₹8.00 | ₹7.78 | -0.38% |
Thu, Oct 3 2024 | ₹7.78 | ₹7.81 |